BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28621643)

  • 1. The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations.
    Atkin W; Brenner A; Martin J; Wooldrage K; Shah U; Lucas F; Greliak P; Pack K; Kralj-Hans I; Thomson A; Perera S; Wood J; Miles A; Wardle J; Kearns B; Tappenden P; Myles J; Veitch A; Duffy SW
    Health Technol Assess; 2017 Apr; 21(25):1-536. PubMed ID: 28621643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study.
    Cross AJ; Robbins EC; Pack K; Stenson I; Kirby PL; Patel B; Rutter MD; Veitch AM; Saunders BP; Little M; Gray A; Duffy SW; Wooldrage K
    Health Technol Assess; 2022 May; 26(26):1-156. PubMed ID: 35635015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study.
    Atkin W; Wooldrage K; Brenner A; Martin J; Shah U; Perera S; Lucas F; Brown JP; Kralj-Hans I; Greliak P; Pack K; Wood J; Thomson A; Veitch A; Duffy SW; Cross AJ
    Lancet Oncol; 2017 Jun; 18(6):823-834. PubMed ID: 28457708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
    Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S
    Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Risk of Colorectal Cancer After Removal of Conventional Adenomas and Serrated Polyps.
    He X; Hang D; Wu K; Nayor J; Drew DA; Giovannucci EL; Ogino S; Chan AT; Song M
    Gastroenterology; 2020 Mar; 158(4):852-861.e4. PubMed ID: 31302144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of advanced neoplasia during surveillance in high- and intermediate-risk groups of the European colorectal cancer screening guidelines.
    Cubiella J; Carballo F; Portillo I; Cruzado Quevedo J; Salas D; Binefa G; Milà N; Hernández C; Andreu M; Terán Á; Arana-Arri E; Ono A; Valverde MJ; Bujanda L; Hernández V; Morillas JD; Jover R; Castells A
    Endoscopy; 2016 Nov; 48(11):995-1002. PubMed ID: 27485482
    [No Abstract]   [Full Text] [Related]  

  • 11. Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study.
    Robbins EC; Wooldrage K; Stenson I; Pack K; Duffy S; Weller D; Levin T; Conell C; Wright S; Nickerson C; Martin J; Cross AJ
    Endoscopy; 2021 Apr; 53(4):402-410. PubMed ID: 32814350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
    Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
    Trials; 2013 Jul; 14():237. PubMed ID: 23895505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term colorectal cancer incidence after adenoma removal and the effects of surveillance on incidence: a multicentre, retrospective, cohort study.
    Cross AJ; Robbins EC; Pack K; Stenson I; Kirby PL; Patel B; Rutter MD; Veitch AM; Saunders BP; Duffy SW; Wooldrage K
    Gut; 2020 Sep; 69(9):1645-1658. PubMed ID: 31953252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population.
    Lee JK; Jensen CD; Levin TR; Doubeni CA; Zauber AG; Chubak J; Kamineni AS; Schottinger JE; Ghai NR; Udaltsova N; Zhao WK; Fireman BH; Quesenberry CP; Orav EJ; Skinner CS; Halm EA; Corley DA
    Gastroenterology; 2020 Mar; 158(4):884-894.e5. PubMed ID: 31589872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.
    Meester RGS; Lansdorp-Vogelaar I; Winawer SJ; Zauber AG; Knudsen AB; Ladabaum U
    Ann Intern Med; 2019 Nov; 171(9):612-622. PubMed ID: 31546257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline Colonoscopy Findings Associated With 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance.
    Lieberman D; Sullivan BA; Hauser ER; Qin X; Musselwhite LW; O'Leary MC; Redding TS; Madison AN; Bullard AJ; Thomas R; Sims KJ; Williams CD; Hyslop T; Weiss D; Gupta S; Gellad ZF; Robertson DJ; Provenzale D
    Gastroenterology; 2020 Mar; 158(4):862-874.e8. PubMed ID: 31376388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening Colonoscopies.
    Wieszczy P; Kaminski MF; Franczyk R; Loberg M; Kobiela J; Rupinska M; Kocot B; Rupinski M; Holme O; Wojciechowska U; Didkowska J; Ransohoff D; Bretthauer M; Kalager M; Regula J
    Gastroenterology; 2020 Mar; 158(4):875-883.e5. PubMed ID: 31563625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study.
    Cross AJ; Wooldrage K; Robbins EC; Kralj-Hans I; MacRae E; Piggott C; Stenson I; Prendergast A; Patel B; Pack K; Howe R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran SP; Atkin WS
    Gut; 2019 Sep; 68(9):1642-1652. PubMed ID: 30538097
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.